NEW YORK (GenomeWeb News) - Illumina President and CEO Jay Flatley today introduced two new sequencing platforms, new technological advances in the firm’s optics and flow cells, and reported preliminary fourth quarter figures for the firm.

He also said that the firm's technology can now produce a human genome for under $1,000, claiming to be the first to achieve this long sought-after goal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.